{"answer":{"query":"Myrbetriq","resolved_as":"applications","packages":7,"applications":["NDA202611","NDA213801"],"identity":{"application_numbers":["NDA202611","NDA213801"],"marketing_categories":["NDA"],"labelers":[],"dosage_forms":[{"text":"TABLET, FILM COATED, EXTENDED RELEASE","untrusted":true},{"text":"GRANULE, FOR SUSPENSION, EXTENDED RELEASE","untrusted":true}],"marketing_start":{"earliest":"2012-06-28","latest":"2021-03-25","packages_with_a_start_date":7}},"generic_entry":[{"application":"NDA202611","date":"2030-03-28","reading":"upper bound from listed dates, not a forecast","basis":"latest of all listed patent and exclusivity expiries in this Orange Book edition; an upper bound from listed dates only, not a forecast of launch (litigation, settlements, delisting, tentative approvals and 180-day status are not modelled)","driver":{"kind":"patent","ref":"10842780*PED","productNo":"001"},"latest_patent_expiry":"2030-03-28","latest_exclusivity_expiry":"NOT_PROVIDED","dated_barriers":20,"undated_barriers":0,"orange_book_edition":"2026-09","patents_listed":5,"exclusivities_listed":0,"fact_id":"bc86f14d92c828e037ce001f"},{"application":"NDA213801","date":"2036-09-30","reading":"upper bound from listed dates, not a forecast","basis":"latest of all listed patent and exclusivity expiries in this Orange Book edition; an upper bound from listed dates only, not a forecast of launch (litigation, settlements, delisting, tentative approvals and 180-day status are not modelled)","driver":{"kind":"patent","ref":"10058536*PED","productNo":"001"},"latest_patent_expiry":"2036-09-30","latest_exclusivity_expiry":"NOT_PROVIDED","dated_barriers":2,"undated_barriers":0,"orange_book_edition":"2026-09","patents_listed":1,"exclusivities_listed":0,"fact_id":"8f71cffd4d4ae13cb8559430"}],"label_history":{"events_total":11,"non_cmc_events":6,"counts_by_class":{"EFFICACY":2,"LABELING":4},"cmc_events":5,"recent_non_cmc_events":[{"application":"NDA202611","submission_no":17,"class_code":"EFFICACY","class_description":{"text":"Efficacy","untrusted":true},"status":"AP","date":"2021-03-25","documents":[{"type":"Label","date":"2021-03-26","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202611s017,213801s000lbl.pdf","untrusted":true}},{"type":"Letter","date":"2021-03-30","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/202611Orig1s017ltr.pdf","untrusted":true}}],"fact_id":"5cb7a93a93dd3ed35270ffd2"},{"application":"NDA202611","submission_no":11,"class_code":"EFFICACY","class_description":{"text":"Efficacy","untrusted":true},"status":"AP","date":"2018-04-27","documents":[{"type":"Letter","date":"2018-05-03","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/202611Orig1s011ltr.pdf","untrusted":true}},{"type":"Label","date":"2018-05-07","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202611s011lbl.pdf","untrusted":true}}],"fact_id":"32c3496f1097f4121e49bdd7"},{"application":"NDA202611","submission_no":12,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2017-07-28","documents":[{"type":"Label","date":"2017-07-31","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202611s012lbl.pdf","untrusted":true}},{"type":"Letter","date":"2017-08-02","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/202611Orig1s012ltr.pdf","untrusted":true}}],"fact_id":"10956cbf4a8b35ffe0b09046"},{"application":"NDA202611","submission_no":7,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2016-08-16","documents":[{"type":"Label","date":"2016-08-17","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202611s007lbl.pdf","untrusted":true}},{"type":"Letter","date":"2016-08-16","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/202611Orig1s007ltr.pdf","untrusted":true}}],"fact_id":"92a3db858c6489d2b6d9e3cc"},{"application":"NDA202611","submission_no":5,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2015-11-02","documents":[{"type":"Label","date":"2015-11-04","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202611s005lbl.pdf","untrusted":true}},{"type":"Letter","date":"2015-11-04","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/202611Orig1s005ltr.pdf","untrusted":true}}],"fact_id":"e8ae7d64d4dc3a632dd6c054"}],"note":"a dated list of FDA supplements and their classes, not a reading of what changed in the label"},"substitution":{"products_total":3,"te_code_counts":{"AB":3},"marketing_status_counts":{"Prescription":3},"meaning":"raw FDA codes; the therapeutic equivalence code says whether FDA rates a generic as substitutable, and what that means for a given prescription is for a pharmacist or prescriber","products":[{"application":"NDA202611","product_no":"001","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"MYRBETRIQ","untrusted":true},"form":{"text":"TABLET, EXTENDED RELEASE;ORAL","untrusted":true},"strength":{"text":"25MG","untrusted":true}},{"application":"NDA202611","product_no":"002","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"MYRBETRIQ","untrusted":true},"form":{"text":"TABLET, EXTENDED RELEASE;ORAL","untrusted":true},"strength":{"text":"50MG","untrusted":true}},{"application":"NDA213801","product_no":"001","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"MYRBETRIQ GRANULES","untrusted":true},"form":{"text":"FOR SUSPENSION, EXTENDED RELEASE;ORAL","untrusted":true},"strength":{"text":"8MG/ML","untrusted":true}}]},"spending":{"reported_under":{"generic":{"text":"Mirabegron","untrusted":true},"brand":{"text":"Myrbetriq","untrusted":true}},"latest_year":2024,"series":[{"year":2020,"gross_spending_usd":1749232347.3,"claims":3072674,"beneficiaries":600136,"average_spending_per_claim_usd":569.28666929,"fact_id":"5e62af9673bdcab5cc545a3d"},{"year":2021,"gross_spending_usd":1989099248.1,"claims":3233926,"beneficiaries":665158,"average_spending_per_claim_usd":615.07259231,"fact_id":"6df60890e817eb89665146e3"},{"year":2022,"gross_spending_usd":2252501068,"claims":3458632,"beneficiaries":716234,"average_spending_per_claim_usd":651.26936545,"fact_id":"b15bd63639a39b2d0b10339c"},{"year":2023,"gross_spending_usd":2510288599.9,"claims":3651587,"beneficiaries":769978,"average_spending_per_claim_usd":687.45140124,"fact_id":"f96f6d605fb1c8952048c10c"},{"year":2024,"gross_spending_usd":2297067833.5,"claims":3453189,"beneficiaries":762957,"average_spending_per_claim_usd":665.20188542,"fact_id":"2eee7efb3cb2433d0edbbe3c"}],"rebate_caveat":"CMS's dataset states spending is gross drug cost and does not reflect manufacturers' rebates or other price concessions.","not_a_patient_price":"Spending is the total paid by Medicare, plans and beneficiaries for the drug's claims, not what a patient pays.","meaning":"a drug-level aggregate of Medicare Part D claims for all manufacturers combined; not a formulary, not coverage","source":{"dataset":{"text":"data-year-2024, modified 2026-06-25","untrusted":true},"link":{"text":"https://data.cms.gov/summary-statistics-on-use-and-payments/medicare-medicaid-spending-by-drug/medicare-part-d-spending-by-drug","untrusted":true}}},"medicaid_state_utilization":{"year":2025,"states_with_data":16,"all_states_medicaid_reimbursed_usd":2072268.17,"all_states_medicaid_paid_prescriptions":5205,"top_states":[{"state":"AR","medicaid_paid_prescriptions":1218,"medicaid_reimbursed_usd":542592.5,"total_reimbursed_usd":543808.94,"packages":3,"covers":"fee_for_service_only","fact_id":"ece64772db80c3aae68045d0"},{"state":"SC","medicaid_paid_prescriptions":1227,"medicaid_reimbursed_usd":508444.58,"total_reimbursed_usd":510116.25,"packages":4,"covers":"fee_for_service_only","fact_id":"f5e0f3776497458301320eb0"},{"state":"IA","medicaid_paid_prescriptions":698,"medicaid_reimbursed_usd":296048.27,"total_reimbursed_usd":296048.27,"packages":1,"covers":"fee_for_service_only","fact_id":"ee2fbfbfa4b7338d663255a7"},{"state":"OK","medicaid_paid_prescriptions":653,"medicaid_reimbursed_usd":265611.2,"total_reimbursed_usd":270998.88,"packages":2,"covers":"fee_for_service_only","fact_id":"e8db42dfdeb489ae6b2a11f7"},{"state":"FL","medicaid_paid_prescriptions":235,"medicaid_reimbursed_usd":84517.66,"total_reimbursed_usd":84517.66,"packages":2,"covers":"fee_for_service_only","fact_id":"3420c0e7ec47a3e9a1c99b4e"},{"state":"UT","medicaid_paid_prescriptions":149,"medicaid_reimbursed_usd":67637.21,"total_reimbursed_usd":67637.21,"packages":1,"covers":"fee_for_service_only","fact_id":"da19125089a97fec5f0b8852"},{"state":"VT","medicaid_paid_prescriptions":113,"medicaid_reimbursed_usd":50862.82,"total_reimbursed_usd":50862.82,"packages":1,"covers":"all_record_types","fact_id":"a484ee3e553ffe1dfabcc2d1"},{"state":"MO","medicaid_paid_prescriptions":160,"medicaid_reimbursed_usd":49366.28,"total_reimbursed_usd":49515.16,"packages":2,"covers":"all_record_types","fact_id":"42d624d648ad850d5ec49f71"},{"state":"VA","medicaid_paid_prescriptions":92,"medicaid_reimbursed_usd":41654.42,"total_reimbursed_usd":41654.42,"packages":1,"covers":"fee_for_service_only","fact_id":"1532d22d58d00842c6d52058"},{"state":"TN","medicaid_paid_prescriptions":131,"medicaid_reimbursed_usd":38169.12,"total_reimbursed_usd":39700.5,"packages":1,"covers":"all_record_types","fact_id":"0051384bf476d6554f3a8451"}],"unlabelled_state_code_xx":null,"built_from_facts":24,"facts_fee_for_service_only":12,"older_year_facts_not_used":165,"dataset":"State Drug Utilization Data 2025","read_on":"2026-11-07T22:41:44.201Z","reading":"Medicaid prescriptions and reimbursement by state (CMS State Drug Utilization Data). Reimbursement is before manufacturer rebates: not a net cost, not a patient price. Suppressed managed-care cells make a state figure fee-for-service only. An absent state was suppressed or unreported, not zero.","receipts_note":"a receipt is held for the largest fact behind each state shown; every figure is a sum of the built_from_facts facts, each recomputable from its recorded input hash"}},"receipts":[{"fact_id":"20621ff0033f1a43667b8c78","field":"ndc.listing","entity":"ndc:00469260107"},{"fact_id":"cd3339d592952bb65aad56ce","field":"ndc.listing","entity":"ndc:00469260130"},{"fact_id":"1468c1b28638554eec4f99ad","field":"ndc.listing","entity":"ndc:00469260190"},{"fact_id":"bc86f14d92c828e037ce001f","field":"drug.generic_entry_earliest","entity":"application:NDA202611"},{"fact_id":"c969dd1d0c97a1489ca874f1","field":"drug.patent","entity":"application:NDA202611"},{"fact_id":"8f71cffd4d4ae13cb8559430","field":"drug.generic_entry_earliest","entity":"application:NDA213801"},{"fact_id":"796ae7444d3731532fe177d4","field":"drug.patent","entity":"application:NDA213801"},{"fact_id":"5cb7a93a93dd3ed35270ffd2","field":"drug.label_event","entity":"application:NDA202611"},{"fact_id":"32c3496f1097f4121e49bdd7","field":"drug.label_event","entity":"application:NDA202611"},{"fact_id":"10956cbf4a8b35ffe0b09046","field":"drug.label_event","entity":"application:NDA202611"},{"fact_id":"92a3db858c6489d2b6d9e3cc","field":"drug.label_event","entity":"application:NDA202611"},{"fact_id":"e8ae7d64d4dc3a632dd6c054","field":"drug.label_event","entity":"application:NDA202611"},{"fact_id":"fc16e1fe114cc943874d1727","field":"drug.te_code","entity":"application:NDA202611"},{"fact_id":"29242060fd0b1bacc1d908c8","field":"drug.marketing_status","entity":"application:NDA202611"},{"fact_id":"e268a19402a3f50d529b0071","field":"drug.te_code","entity":"application:NDA202611"},{"fact_id":"11de65bccf7b7adb8e63d811","field":"drug.marketing_status","entity":"application:NDA202611"},{"fact_id":"9c456dbc978a54be80ea8936","field":"drug.te_code","entity":"application:NDA213801"},{"fact_id":"6b039b275b8eb3ae17130abc","field":"drug.marketing_status","entity":"application:NDA213801"},{"fact_id":"5e62af9673bdcab5cc545a3d","field":"drug.partd_spending","entity":"drug:mirabegron|myrbetriq"},{"fact_id":"6df60890e817eb89665146e3","field":"drug.partd_spending","entity":"drug:mirabegron|myrbetriq"},{"fact_id":"b15bd63639a39b2d0b10339c","field":"drug.partd_spending","entity":"drug:mirabegron|myrbetriq"},{"fact_id":"f96f6d605fb1c8952048c10c","field":"drug.partd_spending","entity":"drug:mirabegron|myrbetriq"},{"fact_id":"2eee7efb3cb2433d0edbbe3c","field":"drug.partd_spending","entity":"drug:mirabegron|myrbetriq"},{"fact_id":"ece64772db80c3aae68045d0","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00469260130:AR"},{"fact_id":"f5e0f3776497458301320eb0","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00469260230:SC"},{"fact_id":"ee2fbfbfa4b7338d663255a7","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00469260130:IA"},{"fact_id":"e8db42dfdeb489ae6b2a11f7","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00469260290:OK"},{"fact_id":"3420c0e7ec47a3e9a1c99b4e","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00469260190:FL"},{"fact_id":"da19125089a97fec5f0b8852","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00469260230:UT"},{"fact_id":"a484ee3e553ffe1dfabcc2d1","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00469260190:VT"},{"fact_id":"42d624d648ad850d5ec49f71","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00469260190:MO"},{"fact_id":"1532d22d58d00842c6d52058","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00469260190:VA"},{"fact_id":"0051384bf476d6554f3a8451","field":"ndc.medicaid_state_utilization","entity":"ndc_state:00469502099:TN"}],"as_of":{"newest_fact_retrieved_at":"2026-11-10T20:02:39.475Z"},"edition":{"id":"2026-11","merkleRoot":"006ab9a329709cbe7f56a0e1a7c4a02f897655cdfecf9ca34d199690095adcb6","factCount":212100,"manifestPresent":true},"licence":{"classes":["GREEN"],"note":"Source records are public; this compilation is cited with attribution. See the provenance tool for each fact's licence label."},"unknown":[{"code":"NO_DATA","field":"price","reason":"no NADAC price, negotiated price or federal upper limit for these packages"},{"code":"NO_DATA","field":"recalls","reason":"no FDA enforcement report naming a package of these applications is recorded"},{"code":"NO_DATA","field":"supply","reason":"no FDA shortage row and no termination date for these packages"},{"code":"NO_DATA","field":"trials","reason":"no ClinicalTrials.gov record set for this drug's ingredient is in the edition"},{"code":"NO_DATA","field":"assistance_and_offers","reason":"no assistance program lists this drug and no manufacturer offer naming it is recorded; that does not mean none exists"},{"code":"NO_DATA","field":"policy","reason":"no Federal Register event in the edition names this drug or its programs"},{"code":"NO_DATA","field":"biologic_status","reason":"no biologic application of this drug has a Purple Book status in the edition (a drug that is not a biologic has none)"},{"code":"NO_DATA","field":"payment_limit","reason":"no HCPCS code whose NDC crosswalk names a package of these applications has a Part B payment limit in the edition"},{"code":"NO_DATA","field":"rems","reason":"no REMS@FDA program is tied to these applications in the edition (most drugs have none)"},{"code":"NO_DATA","field":"controlled_schedule","reason":"no DEA schedule entry matched this drug's ingredient in the edition"},{"code":"NO_DATA","field":"orphan_designation","reason":"no FDA orphan designation for this drug's ingredient is in the edition"},{"code":"NO_DATA","field":"safety_communication","reason":"no FDA Drug Safety Communication names this drug's ingredient in the edition"}],"disclaimer":"OmniRx is a reference layer of dated public facts, not clinical advice and not a guarantee of price, coverage or eligibility. Each answer lists the facts it rests on."}